Gyre Therapeutics
GYRE
#5535
Rank
C$1.41 B
Marketcap
$16.43
Share price
-8.99%
Change (1 day)
-5.80%
Change (1 year)

P/S ratio for Gyre Therapeutics (GYRE)

P/S ratio at the end of 2023: 17.3

According to Gyre Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.8. At the end of 2023 the company had a P/S ratio of 17.3.

P/S ratio history for Gyre Therapeutics from 2023 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202317.3